Opportunity Information: Apply for HRSA 26 014

Fostering Collaboration Across Ryan White HIV/AIDS Programs (RWHAPs) to Engage People with HIV in Care is a Health Resources and Services Administration (HRSA) cooperative agreement designed to tighten coordination across the different parts of the Ryan White HIV/AIDS Program within selected states, with the practical aim of finding people with HIV who are not currently in care and helping jurisdictions bring them into sustained HIV treatment. The core idea is that many communities already have pieces of the solution spread across RWHAP Parts A, B, C, D, and the Part F AIDS Education and Training Centers (AETCs), but those pieces are not always aligned in a way that consistently reaches people who have fallen out of care. By strengthening collaboration, mapping resources, and turning plans into specific joint actions, the opportunity supports state and local goals tied to Ending the HIV Epidemic efforts and to each jurisdiction's Integrated HIV Prevention and Care Plan, including the Statewide Coordinated Statement of Need (SCSN).

The award will fund one organization to serve as a technical assistance (TA) provider. That TA provider is responsible for planning and coordinating statewide convenings in eight states, bringing together leaders and implementers from the major RWHAP components (Parts A, B, C, and D, plus Part F AETCs). The convening model is meant to be flexible and responsive: the TA provider can use a mix of virtual preparatory meetings and an in-person statewide meeting, depending on what local recipients need to make the work productive. A key expectation is that high-level state stakeholders, such as state health officers, will be invited into the process so the resulting plan has stronger support, faster decision-making, and a clearer path to implementation across agencies and systems.

A major deliverable for each state is a comprehensive asset map that identifies existing resources and services, gaps, and potential new partners that could help reach out-of-care populations. This mapping is not just an inventory; it is intended to surface where collaboration could unlock underused capacity, reduce duplication, improve referral pathways, and connect HIV service systems with other sectors that influence care engagement (for example, community-based organizations, tribal organizations, faith-based organizations, training and clinical workforce supports through AETCs, and other local service providers). Using that asset map and the convening discussions, participants will develop a concrete action plan that lays out specific steps to locate, re-engage, and retain people with HIV who are not currently receiving ongoing HIV medical care.

State selection will be driven by unmet need data, with particular attention to states that are not receiving Ending the HIV Epidemic in the U.S. (EHE) initiative funds. The rationale is both public health and equity-focused: improving engagement in care and increasing viral suppression reduces HIV transmission because people who are virally suppressed do not transmit HIV sexually, and the notice highlights that a large share of new infections is associated with people with HIV who are not yet successfully engaged in care. In other words, the work is framed as a systems-level strategy to reduce preventable infections by strengthening care engagement and continuity, not simply as a planning exercise.

From a funding and administrative standpoint, this is a discretionary HRSA opportunity (CFDA 93.145) offered as a cooperative agreement, meaning HRSA will likely have substantial involvement in shaping and overseeing the project as it is carried out. The opportunity number is HRSA-26-014. HRSA expects to make one award, with a ceiling of $1,500,000. The original closing date listed is 2025-11-17, and the opportunity was created on 2025-09-15.

Eligibility is broad and includes national organizations; state, local, and Indian tribal governments; institutions of higher education; other non-profit organizations (including faith-based, community-based, and tribal organizations); and academic health science centers. In practice, the successful applicant will need to demonstrate they can operate as a high-capacity TA provider: convening and facilitating multi-part stakeholder groups, producing usable resource and partner maps, coordinating across multiple states and RWHAP parts, and guiding the development of action plans that are specific enough to implement and track, while still tailored to the realities of each state and the out-of-care populations most affected there.

  • The Health Resources and Services Administration in the health sector is offering a public funding opportunity titled "Fostering Collaboration Across Ryan White HIV/AIDS Programs (RWHAPs) to Engage People with HIV in Care" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.145.
  • This funding opportunity was created on 2025-09-15.
  • Applicants must submit their applications by 2025-11-17. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Each selected applicant is eligible to receive up to $1,500,000.00 in funding.
  • The number of recipients for this funding is limited to 1 candidate(s).
  • Eligible applicants include: Others.
Apply for HRSA 26 014

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Frequently Asked Questions (FAQs)

1. What is the purpose of the "Fostering Collaboration Across Ryan White HIV/AIDS Programs (RWHAPs) to Engage People with HIV in Care" opportunity?

This HRSA cooperative agreement is designed to strengthen coordination across multiple parts of the Ryan White HIV/AIDS Program within selected states so jurisdictions can more effectively find people with HIV who are not currently in care and support their re-engagement and long-term retention in HIV medical care.

2. Who is offering this funding opportunity?

The opportunity is offered by the Health Resources and Services Administration (HRSA).

3. What type of funding mechanism is this?

It is a cooperative agreement. That generally indicates HRSA will have substantial involvement in shaping and overseeing the work as the project is implemented.

4. What is the opportunity number?

The opportunity number is HRSA-26-014.

5. What is the CFDA number associated with this opportunity?

The CFDA number is 93.145.

6. How many awards does HRSA expect to make under this announcement?

HRSA expects to make one award.

7. What is the maximum award amount?

The award ceiling is $1,500,000.

8. What is the closing date for applications?

The original closing date listed is 2025-11-17.

9. When was this opportunity created?

The opportunity was created on 2025-09-15.

10. What is the central problem this project is trying to solve?

The project targets a common systems challenge: many communities have existing services and capacity spread across different RWHAP components, but those pieces are not always aligned in ways that consistently identify and re-engage people with HIV who have fallen out of care. The goal is to improve coordination so fewer people are missed and more people stay in sustained treatment.

11. How does the opportunity relate to Ending the HIV Epidemic (EHE) efforts?

The work is intended to support state and local goals tied to Ending the HIV Epidemic efforts and to each jurisdiction's Integrated HIV Prevention and Care Plan, including the Statewide Coordinated Statement of Need (SCSN).

12. How will states be selected for participation?

State selection will be driven by unmet need data, with particular attention to states that are not receiving Ending the HIV Epidemic in the U.S. (EHE) initiative funds.

13. What is the practical public health rationale described for focusing on people who are out of care?

The notice frames this as a systems-level strategy to reduce preventable infections by improving engagement in care and increasing viral suppression. It highlights that people who are virally suppressed do not transmit HIV sexually and that a large share of new infections is associated with people with HIV who are not successfully engaged in care.

14. What will the funded organization actually do?

The funded organization will serve as a technical assistance (TA) provider. Its role includes planning and coordinating statewide convenings in eight states, facilitating collaboration among major RWHAP components, and guiding participants to develop concrete products such as asset maps and action plans focused on locating, re-engaging, and retaining people with HIV who are not currently receiving ongoing HIV medical care.

15. How many states will the TA provider work with?

The TA provider will plan and coordinate statewide convenings in eight states.

16. Which RWHAP parts and components are expected to be involved?

The convenings are expected to bring together leaders and implementers from RWHAP Parts A, B, C, and D, plus Part F AIDS Education and Training Centers (AETCs).

17. What does the convening model look like?

The convening model is intended to be flexible and responsive to local needs. It can include a mix of virtual preparatory meetings and an in-person statewide meeting, depending on what recipients in each state need to make the work productive.

18. Are high-level state leaders expected to participate?

Yes. A key expectation is that high-level state stakeholders, such as state health officers, will be invited into the process to strengthen support, speed decision-making, and improve the path to implementation across agencies and systems.

19. What is an "asset map" in this project, and why is it required?

For each participating state, a major deliverable is a comprehensive asset map that identifies existing resources and services, gaps, and potential new partners that could help reach out-of-care populations. The asset map is intended to do more than list services; it is meant to reveal opportunities to unlock underused capacity, reduce duplication, improve referral pathways, and connect HIV service systems with other relevant sectors.

20. What kinds of partners might be included in the asset mapping?

The mapping may include a broad range of entities that influence care engagement, such as community-based organizations, tribal organizations, faith-based organizations, training and clinical workforce supports through AETCs, and other local service providers.

21. What is the expected outcome after the asset mapping and convenings?

Using the asset map and convening discussions, participants will develop a concrete action plan with specific steps to locate, re-engage, and retain people with HIV who are not currently receiving ongoing HIV medical care.

22. Is the work mainly planning, or does it emphasize implementation?

While planning is part of the approach, the opportunity emphasizes turning plans into specific joint actions. The action plans are expected to be concrete enough to implement and track, while still being tailored to each state's realities and the out-of-care populations most affected there.

23. Who is eligible to apply?

Eligibility includes national organizations; state, local, and Indian tribal governments; institutions of higher education; other non-profit organizations (including faith-based, community-based, and tribal organizations); and academic health science centers.

24. Does this opportunity require the applicant to be located in a participating state?

The information provided notes that eligibility is broad and includes national organizations. It does not state that the applicant must be located in one of the participating states.

25. What capabilities should a competitive applicant demonstrate?

The successful applicant is expected to operate as a high-capacity TA provider, including the ability to convene and facilitate multi-part stakeholder groups; produce usable resource and partner maps; coordinate across multiple states and RWHAP parts; and guide the development of action plans that are specific enough to implement and track, while tailored to each state and its out-of-care populations.

26. Why does the opportunity emphasize coordination across RWHAP Parts A, B, C, D, and Part F AETCs?

The core idea presented is that many jurisdictions already have "pieces of the solution" across these program components, but those pieces are not always aligned. Strengthening collaboration is intended to improve referral pathways, reduce duplication, and make care re-engagement efforts more consistent and effective.

27. What planning frameworks or jurisdictional documents does this effort connect to?

The opportunity is described as supporting goals tied to Ending the HIV Epidemic efforts and to each jurisdiction's Integrated HIV Prevention and Care Plan, including the Statewide Coordinated Statement of Need (SCSN).

28. What is the main role of HRSA during the project?

Because this is a cooperative agreement, HRSA is expected to have substantial involvement in shaping and overseeing how the project is carried out, rather than being a hands-off funder.

Browse more opportunities from the same agency: Health Resources and Services Administration

Browse more opportunities from the same category: Health

Previous opportunity: National Alzheimers Coordinating Center (U24 Clinical Trial Not Allowed)

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for HRSA 26 014

 

Applicants also applied for:

Applicants who have applied for this opportunity (HRSA 26 014) also looked into and applied for these:

Funding Opportunity
Optimizing Treatment Strategies for Adult Attention-Deficit Hyperactivity Disorder (ADHD) (R01 Clinical Trial Required) Apply for RFA MH 26 195

Funding Number: RFA MH 26 195
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Limited Competition: National Biocontainment Laboratories (NBLs) Operations Support (UC7 Clinical Trials Not Allowed) Apply for RFA AI 25 013

Funding Number: RFA AI 25 013
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Pilot Projects to Enhance the Human Virome Program (R03, Clinical Trials Not Allowed) Apply for RFA RM 25 006

Funding Number: RFA RM 25 006
Agency: National Institutes of Health
Category: Health
Funding Amount: $100,000
Rational Design of Vaccines Against Hepatitis C Virus (U19 Clinical Trial Not Allowed) Apply for RFA AI 25 012

Funding Number: RFA AI 25 012
Agency: National Institutes of Health
Category: Health
Funding Amount: $2,000,000
Mind and Body Interventions to Restore Whole Person Health via Emotional Well-Being Mechanisms (R61/R33 Clinical Trial Required) Apply for PAR 25 449

Funding Number: PAR 25 449
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01 - Clinical Trial Not Allowed) Apply for PAR 25 447

Funding Number: PAR 25 447
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Viral INfections in the Young Lung- The VINYL Clinical Consortium (UG3/UH3 Clinical Trial Optional) Apply for RFA HL 26 006

Funding Number: RFA HL 26 006
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Viral INfections in the Young Lung- The VINYL Clinical Consortium- Data Analytics and Coordinating Center (DACC)(U24 Clinical Trial Optional) Apply for RFA HL 26 008

Funding Number: RFA HL 26 008
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Drug-Free Communities (DFC) Support Program – COMPETING CONTINUATION (Year 6) Apply for CDC RFA CE21 210206CONT26

Funding Number: CDC RFA CE21 210206CONT26
Agency: Centers for Disease Control - NCIPC
Category: Health
Funding Amount: $125,000
Drug-Free Communities (DFC) Support Program – NEW (Year 1) Apply for CDC RFA CE 26 0061

Funding Number: CDC RFA CE 26 0061
Agency: Centers for Disease Control - NCIPC
Category: Health
Funding Amount: $125,000
Comprehensive Addiction and Recovery Act (CARA) Apply for CDC RFA CE 26 0110

Funding Number: CDC RFA CE 26 0110
Agency: Centers for Disease Control - NCIPC
Category: Health
Funding Amount: $75,000
Teaching Health Center Graduate Medical Education (THCGME) Program Apply for HRSA 26 011

Funding Number: HRSA 26 011
Agency: Health Resources and Services Administration
Category: Health
Funding Amount: $3,840,000
Ryan White HIV/AIDS Program AIDS Drug Assistance Program (ADAP) Emergency Relief Fund (ERF)  Apply for HRSA 26 012

Funding Number: HRSA 26 012
Agency: Health Resources and Services Administration
Category: Health
Funding Amount: $10,000,000
Innovation in Behavioral Health (IBH) Apply for CMS 2Q2 26 001

Funding Number: CMS 2Q2 26 001
Agency: Centers for Medicare Medicaid Services
Category: Health
Funding Amount: $7,500,000
Single Source Renewal for the Continuation of the Liver Cirrhosis Network: Scientific and Data Coordination Center (U24 Clinical Trial Optional) Apply for RFA DK 26 309

Funding Number: RFA DK 26 309
Agency: National Institutes of Health
Category: Health
Funding Amount: $1,850,000
Limited Competition Renewal for the Continuation of the Liver Cirrhosis Network: Clinical Research Centers (U01 Clinical Trial Required) Apply for RFA DK 26 308

Funding Number: RFA DK 26 308
Agency: National Institutes of Health
Category: Health
Funding Amount: $330,214
Institutional Network Award for Promoting Kidney, Urologic, and Hematologic Research Training (U2C - Clinical Trial Not Allowed) Apply for PAR 26 115

Funding Number: PAR 26 115
Agency: National Institutes of Health
Category: Health
Funding Amount: $2,100,000
Diabetes Research Centers (P30 Clinical Trial Optional) Apply for RFA DK 26 310

Funding Number: RFA DK 26 310
Agency: National Institutes of Health
Category: Health
Funding Amount: $1,000,000
Limited Competition: Outcomes of Electronic Medical Records and Genomics (eMERGE) Genomic Risk Assessment and Management Network - Clinical Sites (U01, Clinical Trial Required) Apply for RFA HG 25 012

Funding Number: RFA HG 25 012
Agency: National Institutes of Health
Category: Health
Funding Amount: $330,000
Informatics, Coordination and Service Center for the Mutant Mouse Resource and Research Centers (U42 Clinical Trial Not Allowed) Apply for RFA OD 25 012

Funding Number: RFA OD 25 012
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "HRSA 26 014", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: